The present invention provides the body SGLT inhibited compound that cotransports to sodium dependent glucose. The present invention also provides pharmaceutical composition, the method for preparing the compound, synthetic intermediate and the methods for being used independently or being combined the compound with other therapeutic agents to treat the disease and illness that are influenced by SGLT inhibition.本發明提供對鈉依賴性葡萄糖共轉運體SGLT具有抑制作用的化合物。本發明還提供藥物組合物、製備所述化合物的方法、合成中間體及獨立地使用或與其他治療劑聯用所述化合物以治療受SGLT抑制影響的疾病和病症的方法。